Annual CAPEX
$331.40 M
+$96.10 M+40.84%
31 March 2024
Summary:
Dr Reddys Laboratories Limited annual capital expenditures is currently $331.40 million, with the most recent change of +$96.10 million (+40.84%) on 31 March 2024. During the last 3 years, it has risen by +$162.51 million (+96.22%). RDY annual CAPEX is now -45.78% below its all-time high of $611.18 million, reached on 31 March 2017.RDY CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$94.09 M
0.00%
01 September 2024
Summary:
Dr Reddys Laboratories Limited quarterly capital expenditures is currently $94.09 millionOver the past year, it has increased by +$34.89 million (+58.93%). RDY quarterly CAPEX is now -76.44% below its all-time high of $399.37 million, reached on 30 September 2016.RDY Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$230.66 M
0.00%
01 September 2024
Summary:
Dr Reddys Laboratories Limited TTM capital expenditures is currently $230.66 millionOver the past year, it has dropped by -$74.58 million (-24.43%). RDY TTM CAPEX is now -64.16% below its all-time high of $643.51 million, reached on 30 September 2016.RDY TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RDY CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +40.8% | +58.9% | -24.4% |
| 3 y3 years | +96.2% | +62.1% | -5.0% |
| 5 y5 years | +176.8% | +396.5% | +154.8% |
RDY CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +96.2% | -36.5% | +181.3% | -30.4% | at low |
| 5 y | 5 years | at high | +284.9% | -36.5% | +396.5% | -30.4% | +167.9% |
| alltime | all time | -45.8% | +3010.1% | -76.4% | +7608.2% | -64.2% | +8213.1% |
Dr Reddys Laboratories Limited CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $94.09 M(+21.6%) | $230.66 M(-30.4%) |
| Mar 2024 | $331.40 M(+40.8%) | $77.37 M(+30.7%) | $331.40 M(+8.6%) |
| Dec 2023 | - | $59.20 M(+26.8%) | $305.24 M(+9.2%) |
| Sept 2023 | - | $46.69 M(-68.5%) | $279.49 M(+3.2%) |
| June 2023 | - | $148.15 M(+189.3%) | $270.82 M(+15.1%) |
| Mar 2023 | $235.31 M(-8.0%) | $51.21 M(+53.1%) | $235.31 M(-1.7%) |
| Dec 2022 | - | $33.45 M(-12.0%) | $239.42 M(-9.3%) |
| Sept 2022 | - | $38.02 M(-66.2%) | $264.01 M(-18.3%) |
| June 2022 | - | $112.64 M(+103.6%) | $323.10 M(+26.4%) |
| Mar 2022 | $255.72 M(+51.4%) | $55.32 M(-4.7%) | $255.72 M(+5.3%) |
| Dec 2021 | - | $58.04 M(-40.2%) | $242.76 M(-2.9%) |
| Sept 2021 | - | $97.11 M(+114.6%) | $249.99 M(+32.0%) |
| June 2021 | - | $45.25 M(+6.8%) | $189.32 M(+12.1%) |
| Mar 2021 | $168.89 M(+96.1%) | $42.36 M(-35.1%) | $168.89 M(+8.1%) |
| Dec 2020 | - | $65.27 M(+79.1%) | $156.29 M(+42.1%) |
| Sept 2020 | - | $36.44 M(+46.8%) | $109.96 M(+21.8%) |
| June 2020 | - | $24.82 M(-16.6%) | $90.28 M(+4.8%) |
| Mar 2020 | $86.11 M(-28.1%) | $29.76 M(+57.0%) | $86.11 M(-4.9%) |
| Dec 2019 | - | $18.95 M(+13.1%) | $90.52 M(-3.5%) |
| Sept 2019 | - | $16.75 M(-18.9%) | $93.80 M(-8.9%) |
| June 2019 | - | $20.65 M(-39.5%) | $102.92 M(-14.0%) |
| Mar 2019 | $119.74 M(-30.1%) | $34.16 M(+53.7%) | $119.74 M(+7.3%) |
| Dec 2018 | - | $22.23 M(-14.1%) | $111.63 M(-20.5%) |
| Sept 2018 | - | $25.87 M(-31.0%) | $140.43 M(-15.4%) |
| June 2018 | - | $37.47 M(+43.8%) | $166.05 M(-3.1%) |
| Mar 2018 | $171.29 M(-72.0%) | $26.06 M(-48.9%) | $171.29 M(-13.5%) |
| Dec 2017 | - | $51.03 M(-0.9%) | $198.10 M(+4.6%) |
| Sept 2017 | - | $51.49 M(+20.5%) | $189.47 M(-64.7%) |
| June 2017 | - | $42.72 M(-19.2%) | $537.36 M(-12.1%) |
| Mar 2017 | $611.18 M(+168.8%) | $52.87 M(+24.7%) | $611.18 M(-0.5%) |
| Dec 2016 | - | $42.40 M(-89.4%) | $614.06 M(-4.6%) |
| Sept 2016 | - | $399.37 M(+242.7%) | $643.51 M(+114.8%) |
| June 2016 | - | $116.53 M(+109.0%) | $299.62 M(+31.8%) |
| Mar 2016 | $227.39 M(-9.3%) | $55.75 M(-22.4%) | $227.39 M(+3.7%) |
| Dec 2015 | - | $71.85 M(+29.5%) | $219.18 M(-20.3%) |
| Sept 2015 | - | $55.49 M(+25.3%) | $274.84 M(+6.6%) |
| June 2015 | - | $44.30 M(-6.8%) | $257.76 M(+2.8%) |
| Mar 2015 | $250.74 M(+42.2%) | $47.54 M(-62.7%) | $250.74 M(+3.7%) |
| Dec 2014 | - | $127.52 M(+232.1%) | $241.78 M(+53.9%) |
| Sept 2014 | - | $38.40 M(+3.0%) | $157.08 M(-10.8%) |
| June 2014 | - | $37.28 M(-3.4%) | $176.08 M(-0.2%) |
| Mar 2014 | $176.37 M(+30.7%) | $38.58 M(-9.9%) | $176.37 M(+0.8%) |
| Dec 2013 | - | $42.81 M(-25.4%) | $175.00 M(+6.9%) |
| Sept 2013 | - | $57.40 M(+52.8%) | $163.71 M(+19.3%) |
| June 2013 | - | $37.57 M(+0.9%) | $137.23 M(+1.7%) |
| Mar 2013 | $134.98 M | $37.22 M(+18.1%) | $134.98 M(-6.6%) |
| Dec 2012 | - | $31.51 M(+1.9%) | $144.55 M(+10.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2012 | - | $30.92 M(-12.5%) | $130.51 M(-5.8%) |
| June 2012 | - | $35.32 M(-24.5%) | $138.48 M(-23.0%) |
| Mar 2012 | $179.92 M(-29.4%) | $46.79 M(+167.7%) | $179.92 M(-0.7%) |
| Dec 2011 | - | $17.48 M(-55.1%) | $181.12 M(-36.5%) |
| Sept 2011 | - | $38.89 M(-49.3%) | $285.22 M(-1.7%) |
| June 2011 | - | $76.76 M(+59.9%) | $290.09 M(+13.8%) |
| Mar 2011 | $254.93 M(+181.9%) | $48.00 M(-60.5%) | $254.93 M(+3.3%) |
| Dec 2010 | - | $121.58 M(+177.9%) | $246.81 M(+80.0%) |
| Sept 2010 | - | $43.76 M(+5.2%) | $137.13 M(+11.8%) |
| June 2010 | - | $41.60 M(+4.3%) | $122.64 M(+35.6%) |
| Mar 2010 | $90.43 M(-12.8%) | $39.87 M(+235.1%) | $90.43 M(+27.0%) |
| Dec 2009 | - | $11.90 M(-59.3%) | $71.19 M(-12.0%) |
| Sept 2009 | - | $29.27 M(+211.9%) | $80.91 M(+1.8%) |
| June 2009 | - | $9.39 M(-54.5%) | $79.47 M(-23.4%) |
| Mar 2009 | $103.74 M(-37.8%) | $20.64 M(-4.5%) | $103.74 M(-29.8%) |
| Dec 2008 | - | $21.62 M(-22.3%) | $147.68 M(-11.1%) |
| Sept 2008 | - | $27.83 M(-17.3%) | $166.16 M(-5.9%) |
| June 2008 | - | $33.65 M(-47.9%) | $176.65 M(+5.9%) |
| Mar 2008 | $166.81 M(+58.3%) | $64.58 M(+61.1%) | $166.81 M(+26.6%) |
| Dec 2007 | - | $40.10 M(+4.6%) | $131.80 M(+8.5%) |
| Sept 2007 | - | $38.32 M(+60.9%) | $121.42 M(+15.4%) |
| June 2007 | - | $23.81 M(-19.5%) | $105.24 M(-0.1%) |
| Mar 2007 | $105.37 M(+142.2%) | $29.57 M(-0.5%) | $105.37 M(+17.4%) |
| Dec 2006 | - | $29.72 M(+34.3%) | $89.74 M(+25.1%) |
| Sept 2006 | - | $22.13 M(-7.5%) | $71.76 M(+18.3%) |
| June 2006 | - | $23.94 M(+71.7%) | $60.67 M(+39.5%) |
| Mar 2006 | $43.51 M(+11.4%) | $13.94 M(+18.8%) | $43.51 M(+41.3%) |
| Dec 2005 | - | $11.74 M(+6.2%) | $30.78 M(-20.1%) |
| Sept 2005 | - | $11.05 M(+63.1%) | $38.52 M(+8.6%) |
| June 2005 | - | $6.78 M(+455.1%) | $35.45 M(-9.2%) |
| Mar 2005 | $39.07 M(-25.9%) | $1.22 M(-93.7%) | $39.07 M(-23.6%) |
| Dec 2004 | - | $19.47 M(+143.7%) | $51.13 M(+11.7%) |
| Sept 2004 | - | $7.99 M(-23.1%) | $45.79 M(-14.5%) |
| June 2004 | - | $10.39 M(-21.8%) | $53.53 M(+1.5%) |
| Mar 2004 | $52.71 M(+68.9%) | $13.29 M(-6.0%) | $52.71 M(+8.3%) |
| Dec 2003 | - | $14.13 M(-10.1%) | $48.66 M(+16.0%) |
| Sept 2003 | - | $15.72 M(+64.3%) | $41.94 M(+22.1%) |
| June 2003 | - | $9.57 M(+3.7%) | $34.34 M(+10.0%) |
| Mar 2003 | $31.21 M(+36.9%) | $9.23 M(+24.5%) | $31.21 M(+4.0%) |
| Dec 2002 | - | $7.41 M(-8.8%) | $30.00 M(+6.6%) |
| Sept 2002 | - | $8.12 M(+26.0%) | $28.13 M(+6.3%) |
| June 2002 | - | $6.45 M(-19.6%) | $26.47 M(+16.1%) |
| Mar 2002 | $22.80 M(+114.0%) | $8.02 M(+44.6%) | $22.80 M(+54.2%) |
| Dec 2001 | - | $5.54 M(-14.3%) | $14.79 M(+60.0%) |
| Sept 2001 | - | $6.47 M(+133.1%) | $9.24 M(+233.1%) |
| June 2001 | - | $2.77 M | $2.77 M |
| Mar 2001 | $10.66 M | - | - |
FAQ
- What is Dr Reddys Laboratories Limited annual capital expenditures?
- What is the all time high annual CAPEX for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited annual CAPEX year-on-year change?
- What is Dr Reddys Laboratories Limited quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited quarterly CAPEX year-on-year change?
- What is Dr Reddys Laboratories Limited TTM capital expenditures?
- What is the all time high TTM CAPEX for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited TTM CAPEX year-on-year change?
What is Dr Reddys Laboratories Limited annual capital expenditures?
The current annual CAPEX of RDY is $331.40 M
What is the all time high annual CAPEX for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high annual capital expenditures is $611.18 M
What is Dr Reddys Laboratories Limited annual CAPEX year-on-year change?
Over the past year, RDY annual capital expenditures has changed by +$96.10 M (+40.84%)
What is Dr Reddys Laboratories Limited quarterly capital expenditures?
The current quarterly CAPEX of RDY is $94.09 M
What is the all time high quarterly CAPEX for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high quarterly capital expenditures is $399.37 M
What is Dr Reddys Laboratories Limited quarterly CAPEX year-on-year change?
Over the past year, RDY quarterly capital expenditures has changed by +$34.89 M (+58.93%)
What is Dr Reddys Laboratories Limited TTM capital expenditures?
The current TTM CAPEX of RDY is $230.66 M
What is the all time high TTM CAPEX for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high TTM capital expenditures is $643.51 M
What is Dr Reddys Laboratories Limited TTM CAPEX year-on-year change?
Over the past year, RDY TTM capital expenditures has changed by -$74.58 M (-24.43%)